<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE I</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2004-06-22">22 th June 2004</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Joanne</forename><surname>Mccarthy</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Dept. Genetics and Microbiology</orgName>
								<orgName type="institution">University of Pavia REPORT</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sofia</forename><surname>Macedo</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Dept. Genetics and Microbiology</orgName>
								<orgName type="institution">University of Pavia REPORT</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Franca</forename><surname>Rossi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Dept. Genetics and Microbiology</orgName>
								<orgName type="institution">University of Pavia REPORT</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Menico</forename><surname>Rizzi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Dept. Genetics and Microbiology</orgName>
								<orgName type="institution">University of Pavia REPORT</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE I</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2004-06-22">22 th June 2004</date>
						</imprint>
					</monogr>
					<idno type="MD5">69D7B6D0AADBB86FAE1B9A935BF919C5</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T14:58+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>ID14-EH4 ID14-EH2</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Background -In mammals, the kynurenine pathway is the main route for the degradation of tryptophan exceeding anabolic needs. Cumulating clinical and experimental evidences, suggest that an imbalance in the local concentrations of the metabolites along this pathway in the CNS, could be responsible for the onset and the progression of a broad spectrum of neurological pathologies. In particular, increasing of kynurenic acid significantly correlates with schizophrenia and cognitive impairment, suggesting a key role for this metabolite in the pathophysiology of psychiatric disorders and mental retardation. The synthesis of kynurenic acid in the CNS is guaranteed by the irreversible transamination of L-kynurenine, catalyzed by kynurenine aminotransferases (KATs) which are regarded as important targets for the treatment of correlated neurological disorders.</p><p>Results -The crystal structure of human KAT I has been determined at 2.0 A resolution, and is shown in Fig. <ref type="figure">1</ref>. The analysis of the enzyme active site for the PLP and PMP forms, as well as for the complex with phenylalanine, reveals the presence of a crown of aromatic residues surrounding the substrate binding site, unraveling the molecular determinants responsible for the exquisite specificity shown by the enzyme for kynurenine, paving the way for the rational design of kynuerine analogues of potential medical interest.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0" /><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 :</head><label>1</label><figDesc>Figure 1: Ribbon representation of human kynurenine aminotransferase I in its PLP from</figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>Franca Rossi, Qian Han, Jianyong Li, and Menico Rizzi . Structure of human kynurenine aminotransferase I, a key enzyme for the synthesis of the potent neuroactive compound kynurenic acid. (2004), submitted.1.</p></note>
		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>from:14/10/03 to:15/10/03 from 05/12/03 to:06/12/03</p></div>
			</div>

			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
